Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids
- 1 March 2014
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 133 (3) , 664-669.e5
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 HL092197, R01 NR013391, U01 HL065899)
This publication has 49 references indexed in Scilit:
- F-box protein FBXL19–mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammationNature Immunology, 2012
- Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxiaJournal of Cellular Biochemistry, 2011
- Genomewide Association betweenGLCCI1and Response to Glucocorticoid Therapy in AsthmaNew England Journal of Medicine, 2011
- Asthma symptom perception and obesity in childrenBiological Psychology, 2010
- Lessons learned from variation in response to therapy in clinical trialsJournal of Allergy and Clinical Immunology, 2010
- The multiple dimensions of dyspnea: Review and hypothesesRespiratory Physiology & Neurobiology, 2009
- Genome-wide Association Analysis Identifies PDE4D as an Asthma-Susceptibility GeneThe American Journal of Human Genetics, 2009
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trialJournal of Allergy and Clinical Immunology, 2007
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006